Literature DB >> 12963905

Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis.

Kimberly Hersom1, Maureen P Neary, Hugh P Levaux, Winslow Klaskala, John S Strauss.   

Abstract

BACKGROUND: Isotretinoin is indicated for the treatment of severe, recalcitrant nodular acne. Spontaneous reports have suggested a possible association between isotretinoin and depression that has not been supported by prior studies. Depression has been reported in patients with acne and is common among adolescents.
OBJECTIVE: The objective of this study was to investigate whether there is an association between isotretinoin use and onset of depression.
METHODS: A large retrospective database study was performed through a review of pharmacy claims to evaluate the order of first-recorded isotretinoin and antidepressant dispensings in incident users. The study included 2821 patients, aged 12 to 49 years, who filled isotretinoin prescriptions between June 1, 1999, and March 31, 2000. The ratio of the number of patients who filled isotretinoin prescription first versus second was computed, with adjustment for variations in physician prescribing patterns; a ratio significantly greater than 1.0 indicates a depression-invoking relationship. Similar analyses of minocycline were performed.
RESULTS: Adjusted ratios for all antidepressants and by class were not significantly greater than 1.0. Similar results were found for minocycline.
CONCLUSION: The results do not support an association between the use of isotretinoin and the onset of depression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12963905     DOI: 10.1067/s0190-9622(03)02087-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  15 in total

Review 1.  Isotretinoin, depression and suicide: a review of the evidence.

Authors:  Parker Magin; Dimity Pond; Wayne Smith
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

2.  Comparing time to adverse drug reaction signals in a spontaneous reporting database and a claims database: a case study of rofecoxib-induced myocardial infarction and rosiglitazone-induced heart failure signals in Australia.

Authors:  Izyan A Wahab; Nicole L Pratt; Lisa M Kalisch; Elizabeth E Roughead
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

3.  Initiation of acetylcholinesterase inhibitors and complications of chronic airways disorders in elderly patients.

Authors:  Evan L Thacker; Sebastian Schneeweiss
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Retinoic acid and affective disorders: the evidence for an association.

Authors:  J Douglas Bremner; Kirsty D Shearer; Peter J McCaffery
Journal:  J Clin Psychiatry       Date:  2011-08-23       Impact factor: 4.384

Review 5.  The neurobiology of retinoic acid in affective disorders.

Authors:  J Douglas Bremner; Peter McCaffery
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-07-10       Impact factor: 5.067

Review 6.  Retinoids for prevention and treatment of actinic keratosis.

Authors:  Mayra Ianhez; Luiz Fernando Fróes Fleury; Hélio Amante Miot; Edileia Bagatin
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

Review 7.  Assessing the role of drugs in suicidal ideation and suicidality.

Authors:  David M Reith; Liza Edmonds
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  General medical with depression drugs associated.

Authors:  Donald Rogers; Ronald Pies
Journal:  Psychiatry (Edgmont)       Date:  2008-12

9.  Isotretinoin and psychopathology: a review.

Authors:  Vassilis P Kontaxakis; Demetris Skourides; Panayotis Ferentinos; Beata J Havaki-Kontaxaki; George N Papadimitriou
Journal:  Ann Gen Psychiatry       Date:  2009-01-20       Impact factor: 3.455

10.  The performance of sequence symmetry analysis as a tool for post-market surveillance of newly marketed medicines: a simulation study.

Authors:  Nicole L Pratt; Jenni Ilomäki; Chris Raymond; Elizabeth E Roughead
Journal:  BMC Med Res Methodol       Date:  2014-05-15       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.